Why Were PubMed Central and eLife Discussing PeerJ?
When PubMed Central expedited eLife, PeerJ wondered why. Emails within PMC suggest they were tempted to help PeerJ in the same way. They even talked with eLife about how to handle things.
Something's Rotten in Bethesda, Indeed — How PubMed Central Came to Help Launch and Initially Publish eLife
Circumstantial evidence has become direct evidence — that eLife requested publication in PMC; that PMC collaborated with eLife; that PMC sought to conceal its preferential treatment; and that systems and processes at the NLM regarding PMC inclusion are unclear and open to abuse and misuse.
PubReader — Obscuring Journal Branding for the Sake of Repository Branding
A new way to view journal content in PubMed Central casts journal branding aside for a uniform PMC approach.
PubMed and F1000 Research — Unclear Standards Applied Unevenly
F1000 Research has confusing review and publication practices, and doesn’t call itself a journal, yet is now going to be indexed by PubMed — further eroding the PubMed brand.
New Players, New Priorities — Part 1: Governments and Politics Enter Scientific Publishing
In this first part of a three-part series, the intrusion of governments into scientific publishing is contemplated — its causes, current state, and possible effects.
The Hall of Mirrors — Trying to Explain Why Users Value Free Content Differently
Why would free content be differentially accessed across versions of it, and across publications? A dive into PLoS data leads to a potentially reassuring answer.
PubMed Central's Failures in Handling Conflicts of Interest with eLife
One of the layers of impropriety regarding PubMed Central’s handling of eLife is its mismanagement of conflicts of interest.
How Valuable Is PubMed Central's Early Publication of eLife Content?
What is the likely value of what PubMed Central is providing to eLife by publishing them free online, providing PubMed indexing without delay, and getting them into the market six months early?
What PubMed Central's Drag on Publisher Traffic Could Mean Financially
When you think through all the effects stealing traffic has on online publishing businesses, PubMed Central’s competitive presence looms large — whether you sell subscriptions, ads, or APCs.
More eLife Articles on PubMed Central — The Government Subsidy Continues
More articles are published by PubMed Central at the behest of eLife. It seems taxpayer-funded publishing is just fine for this new group.
PubMed Central or OA Central — More Strange Behaviors at PMC and NLM Paint a Portrait of Biases and Poor Process
More information emerges about PubMed Central, its processes, its relationship with eLife, and its role as a technology provider. Overall, it looks like certain OA friends get special treatment, and the processes you think occur are often short-circuited and may not even be tracked.
Something’s Rotten in Bethesda — The Troubling Tale of PubMed Central, PubMed, and eLife
Last week, PubMed Central became the primary and sole publisher of eLife content, putting its competition with publishers, its manipulation of PubMed indexing criteria, its competition with publishing technology companies, and its clear OA bias into stark relief.
Is PubMed Central Complementing or Competing with Journal Publishers?
Articles deposited into PubMed Central responsible for drawing readers from journal site, a study finds.
Open Access Embargoes — How Long Is Long Enough?
Most publishers offering delayed free access to journal articles set their embargo period more than a decade ago. Is it time to revisit the access embargo?
The Secret Life of Retracted Articles
Retracted papers continue to persist on public websites, in institutional repositories and personal libraries years after they are formally retracted. What can be done to help correct the scientific record?